New Key Statistics Module, Z-Score and F-Score
OTCPK:IDXG Key Ratios
| Market Cap $ M | 6.57 |
| Enterprise Value $ M | 14.26 |
| P/E(ttm) | 4.69 |
| PE Ratio without NRI | 4.03 |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.21 |
| Price/Free Cash Flow | 2.75 |
| Price/Owner Earnings | 3.46 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 31.00 |
| EPS (TTM) $ | 0.32 |
| Beneish M-Score | -3.11 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 5.93 |
| EV-to-EBITDA | 3.79 |
| PEG | -- |
| Shares Outstanding M | 4.38 |
| Net Margin (%) | 4.55 |
| Operating Margin % | 9.08 |
| Pre-tax Margin (%) | 5.31 |
| Quick Ratio | 0.52 |
| Current Ratio | 0.59 |
| ROA % (ttm) | 9.43 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | 41.93 |
| Dividend Yield % | -- |
| Altman Z-Score | -24.29 |
IDXG Number of Guru Trades
IDXG Volume of Guru Trades
Gurus Latest Trades with OTCPK:IDXG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:IDXG is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Interpace Biosciences Inc Insider Transactions
No Available Data
News about OTCPK:IDXG
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers